Toxicity profile of dual methotrexate combinations with gold, hydroxychloroquine, sulphasalazine and minocycline in rheumatoid arthritis patients

Rheumatology International

Volumn 17, Issue 2, 1997, Pages 49-53

  Elkayam, O ^a   Yaron, M ^a   Zhukovsky, G ^a   Segal, R ^a   Caspi, D ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Combination; Methotrexate; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; GOLD; HYDROXYCHLOROQUINE; METHOTREXATE; MINOCYCLINE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; DRUG TOLERABILITY; EYE TOXICITY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; MALE; PIGMENT DISORDER; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SEPSIS; STOMATITIS; VERTIGO;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; GOLD; HUMANS; HYDROXYCHLOROQUINE; MALE; MIDDLE AGED; MINOCYCLINE; RETROSPECTIVE STUDIES; SULFASALAZINE; TREATMENT OUTCOME;

EID: 0030805502     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00006851     Document Type: Article

References (24)

1. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughan WK (1984) Severe functional declines, work disability and increased mortality in seventy five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 27:864-872
2. Rosenthal M (1980) Loss of efficacy of antirheumatic drugs in rheumatoid arthritis. J Rheumatol 7:474
3. Sherrer YS, Block DA, Mitchell DM, Young DY, Fries JF (1986) The development of disability in rheumatoid arthritis patients. Arthritis Rheum 29:494
4. Csuka ME, Carrera Mc Carty DF (1986) Treatment of intractable rheumatoid arthritis with combined cyclophosamide, azathioprine and hydroxychloroquine, a follow up study. JAMA 255:2315
5. Gibson T, Emery P, Armstrong RD, Crisp A, Panayi G (1987) Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis: a comparative study. Br J Rheumatol 46:1770
6. Scott DL, Dawes PT, Tunn E, et al. (1989) Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective randomized placebo controlled study. Br J Rheumatol 28:128-133
7. Wilke WS, Sherrer YR, Clough JR (1989) Combination chemotherapy for severe rheumatoid arthritis. IM Intern Med Specialist 10:59
8. Alarcon GS, Lopez-Mendez A, Walter J, Boerbooms AM, Russel AS, et al. (1992) Radiographic evidence of disease progression on methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients - a meta-analysis. J Rheumatol 19:1868-1873
9. Ianuzzi L, Dawson N, Zein N, Kushner I (1983) Does drug therapy slow radiographic deterioration in rheumatoid arthritis? N Engl J Med 309:1023
10. Tishler M, Caspi D, Yaron M (1993) Long term experience with low dose methotrexate in rheumatoid arthritis. Rheumatol Int 13:103-106
11. Furst DE (1990) Proposition: methotrexate should not be the first second line agent to be used if NSAIDs fail. Semin Arthritis Rheum 20:69-75
12. Wilske KR, Healey LA (1989) Remodeling the pyramid - a concept whose time has come. J Rheumatol 16:565-567
13. Felson DT, Anderson JJ, Meenan RF (1994) The efficacy and toxicity of combination therapy in rheumatoid arthritis. Arthritis Rheum 37:1487-1491
14. Williams HJ, Ward JR, Reading JC, et al. (1992) Comparison of auranofin, methotrexate and the combination of both in the treatment of rheumatoid arthritis. Arthritis Rheum 35:259-269
15. Fries JF, Singh G, Lamert L, et al. (1990) Aspirin, hydroxychloroquine and hepatic enzymes abnormalities with methotrexate in rheumatoid arthritis. Arthritis Rheum 33:1611
16. Combe B, Gutierrezz M, Anaya JM, Sany J (1993) Possible efficacy of hydroxychloroquine on accelerated nodulosis during methotrexate therapy for rheumatoid arthritis. J Rheumatol 20:755-758
17. Brawer AE (1988) The combined use of oral methotrexate and intramuscular gold in rheumatoid arthritis. Arthritis Rheum 31:R10 [Suppl]
18. Rau R, KargerT (1989) The European experience. In: Wilke WS (ed) Methotrexate therapy in rheumatic disease. Marcel Dekker, New York, pp 57-90
19. Morgan SL, Baggott JE, Vaughan WH, et al. (1990) The effect of folic acid supplementation of the toxicity of low dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 33:9-18
20. Baum HL, Selhub J, Rosenberg IH (1981) Antifolate actions of sulfasalazine on intact lymphocytes. J Lab Clin Med 97:779-784
21. Morgan SL, Baggott JE, Alarcon GS (1993) Methotrexate and sulfasalazine combination therapy: is it worth the risk? Arthritis Rheum 36:281-282
22. Buchbinder R, Hall S, Harkness A, et al. (1988) Bone marrow failure with methotrexate in rheumatoid arthritis. J Rheumatol 15:1586-1587
23. Nisar M, Carlisle L, Amos RS (1994) Methotrexate and sulpha-salazine as combination therapy in rheumatoid arthritis. Br J Rheumatol 33:651-654
24. Breedveld FC, Dijkmans BAC, Mattie H (1990) Minocyline treatment for RA. J Rheumatol 17:43-46